NCT01446224View on ClinicalTrials.gov

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

Pazopanib

Patients treated with pazopanib

DRUG

Other anti-VEGFs

Patients treated with other anti-VEGFs including Bevacizumab, Sorafenib, and Sunitinib

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01446224 - Cardiovascular and Torsades de Pointes Monitoring for Pazopanib | Biotech Hunter | Biotech Hunter